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Abstract
Background: It is unclear whether gender and aging influence the characteristics of patients
who undergo coronary artery bypass grafting (CABG).
Methods: We retrospectively reviewed a clinical database of 1,498 patients (male/female =
= 1133/365, age 67 ± 9 years) who underwent CABG at Fukuoka University Hospital from
1994 to 2010.
Results: Male showed significantly younger, higher percentages (%) of smoking and
hyperuricemia (HU), higher levels of serum creatinine, and lower % hypertension (HT) and
diabetes mellitus (DM), and lower levels of left ventricular ejection fraction than female. In
multivariate analysis, all parameters identified independent variables associated with the
gender difference. Next, we divided the patients into 5 groups according to age, and each group
was then separated by gender. The % of males significantly decreased with aging, whereas
% female significantly increased. Although % smoking and estimated glomerular filtration rate
(eGFR), and body mass index (BMI) in all patients, males and females significantly decreased
with aging, HU, left ventricular end diastolic pressure and the number of significantly stenosed
coronary vessels were not associated with gender or aging. Interestingly, % HT in all patients
and males significantly increased with aging, whereas that in females was not associated with
aging. Serum low-density lipoprotein cholesterol levels in males significantly decreased with
aging, while those in all patients and females were not associated with aging. In this
contemporary data set, the decreases in % smoking and eGFR with aging were common
characteristics in male and female patients. In addition, there were gender and aging differences
in % smoking, % HT, BMI and eGFR, whereas no differences were observed in % DM, % dyslipi-
demia or % HU.
Conclusions: Before CABG, high-risk patients with coronary artery disease who is going to
undergo CABG may need to be managed more strictly considering to gender and age to avoid
CABG. (Cardiol J 2012; 19, 6: 618–624)
Key words: coronary artery disease, risk factor, coronary artery bypass grafting,
gender, aging
619
Tomohiko Shimizu et al., Gender and aging in CABG
www.cardiologyjournal.org
Introduction
The incidence of coronary artery disease
(CAD) is closely related to lifestyle, such as smok-
ing, diet, and exercise [1, 2]. We have experienced
a growing need for coronary artery bypass grafting
(CABG) and percutaneous transluminal coronary
angioplasty (PTCA) for CAD in younger patients
because of the adoption of a western diet. Although
CAD is a multifactorial disease that involves multi-
ple loci and environmental factors [3, 4], it is possi-
ble to prevent CAD by aggressively eliminating the
risk factors of CAD [5]. However, while the overall
risk factors of CAD have been well studied, the risks
of undergoing CABG are not known. The relative
risks of CAD for each age group in females are gen-
erally lower than those in males, and the risk of
death due to CAD in females is almost equal to that
in males who are 10 years younger [3]. Thus, there
may also be differences in the characteristics of
patients who undergo CABG with regard to gender
and age.
At the Department of Cardiovascular Surgery,
Fukuoka University Hospital, CABG has been per-
formed in about 1,500 cases over the past 15 years,
and the patient characteristics have been record-
ed. Therefore, we evaluated the patient background
in each age group for patients who underwent
CABG and examined differences in gender and age
in assessing the risk of CABG.
Methods
Subjects
We registered 1,525 patients who underwent
CABG from April 1994 to December 2010 at the
Department of Cardiovascular Surgery, Fukuoka
University Hospital. Patients with Kawasaki dise-
ase (n = 15) or familial hypercholesterolemia
(n = 12) were excluded. The remaining 1,498 were
used for further analysis.
The study was approved by the local ethic com-
mittee.
Assessment of cardiovascular risk factors
To analyze the influence of aging, the patients
were divided into 5 groups according to age; < 50 ye-
ars (Group 1 — G1), 50–59 (G2), 60–69 (G3), 70–
–79 (G4) and ≥ 80 (G5). In addition, to analyze the
influence of gender, we further divided each of these
groups into 2 groups (male and female). Cardiovas-
cular risk factors (smoking, hypertension [HT], dia-
betes mellitus [DM], dyslipidemia [DL], hyperuri-
cemia [HU], estimated glomerular filtration rate
[eGFR], low-density lipoprotein cholesterol [LDL-C],
and body mass index [BMI]) were analyzed. We also
analyzed the left ventricular ejection fraction
(LVEF), left ventricular end-diastolic pressure
(LVEDP) and EuroScore.
Statistical analysis
Statistical analysis was performed using the
Stat View statistical software package (Stat View 5;
SAS Institute INC., Cary, NC) at Fukuoka Univer-
sity. Data are expressed as the mean ± standard
deviation (SD). Categorical and continuous varia-
bles were compared by a c2 analysis and analysis
of variance followed by Fisher’s PLSD, respectively.
Multivariate analysis was performed using a logis-
tic regression analysis for independent variables
that were related to the gender. A value of p < 0.05
was considered significant.
Results
Table 1 shows the patient characteristics for
all of the patients and in male and female. Male
showed significantly younger, higher percentages
(%) of smoking and HU, higher levels of serum cre-
atinine (Cr), and lower % HT and DM, and lower
levels of LVEF and EuroScore than female. Age is
significantly associated with EuroScore because age
over 60 years plus a score of 1 for every 5 years.
These factors were associated with each other.
Therefore, we excluded EuroScore from the logistic
regression analysis and performed the analysis
using independent variables (age, % smoking, % HT,
% DM, % HU, serum Cr, and LVEF) that were re-
lated to the gender (Table 2). All parameters iden-
tified independent variables associated with the
gender difference.
Table 3 shows the patient characteristics for
all of the patients and in G1–G5. The average ages
for all patients, males and females were 67 ± 9,
66 ± 10 and 70 ± 8 years, respectively. Seventy-six
percent of all patients were male and underwent
GABG. The % male with CABG decreased with
aging. Further, BMI values in all patients, males,
and females decreased with aging. % smoking in all
patients, males and females was 21%, 25% and 7%,
respectively. % smoking in both males and females
decreased with aging. % HT in all patients, males
and females was 67%, 65% and 73%, respectively.
% HT in all patients increased with aging. % DL in
all patients, males and females was 57%, 56% and
59%, respectively. % DL in all patients and males
decreased with aging. % DM in all patients, males
and females was 48%, 47%, and 53%, respectively.
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There were significant changes in DM with regard
to age in all patients and females.
Table 4 shows the physiological and biochem-
ical parameters from G1 to G5 groups. eGFR in all
patients, males and females was 57 ± 23, 57 ± 23
and 56 ± 24 mL/min/1.73 m2, respectively, and
there was no difference in eGFR between males and
females (Table 4). The eGFR in all patients, males
and females decreased with aging. The level of
LDL-C in all patients, males and females was 113 ±
± 39, 112 ± 38, and 114 ± 42 mg/dL, respectively,
and there was no difference in LDL-C with aging in all
patients and females. However, the level of LDL-C
in males were significantly decreased with aging.
The LVEF in all patients, males and females was
59 ± 16%, 58 ± 16%, and 62 ± 15%, respectively,
and LVEF in females was significantly higher than
that in males, except for G1. The EuroScore in all
patients, males and females was 5.5 ± 3.6, 5.1 ±
± 3.6, and 6.6 ± 3.5, respectively. The EuroScore
in all patients, males and females increased with ag-
ing. There were no differences in LVEDP or the
number of significantly stenosed coronary vessels
with aging.
Discussion
In this contemporary data set, decreases in
% smoking and eGFR with aging were common pa-
tient characteristics in both male and female pa-
tients. In addition, age, % smoking, % HT, % DM,
% HU, serum Cr and LVEF were related to the
gender identified independent variables. Thus,
high-risk patients with CAD who undergo CABG
should be managed more strictly with regard to
gender and age.
It has been reported that there are differences
in the risk of CAD according to gender and age
[1, 3]. Patients background, such as age, % male, BMI,
% HT, eGFR and EuroScore in this study were com-
parable to the Japanese patients group described in
Table 1. Patient characteristics  and physiological and biochemical parameters.
All Male Female P (male
vs. female)
N (%) 1498 1133 (76%) 365 (24%)
Age (years) 67 ± 9 66 ± 10 70 ± 8 < 0.001
Body mass index [kg/m2] 24 ± 3 24 ± 3 23 ± 4 0.480
Smoking 21% 25% 7% < 0.001
Hypertension 67% 65% 73% 0.006
Diabetes mellitus 48% 47% 73% 0.034
Hyperuricemia 11% 14% 4% < 0.001
Dyslipidemia 57% 56% 59% 0.386
Serum creatinine [mg/dL] 1.5 ± 2.1 1.6 ± 2.3 1.3 ± 1.7 0.003
CKD (stage) 2.7 ± 0.9 2.7 ± 0.9 2.6 ± 1.0 0.696
eGFR [mL/min/1.73 mm2] 57 ± 23 57 ± 23 56 ± 24 0.230
LDL-cholesterol [mg/dL] 113 ± 39 112 ± 38 114 ± 42 0.523
LVEDP [mm Hg] 14 ± 7 14 ± 7 13 ± 7 0.670
Left ventricular ejection fraction (%) 59 ± 16 58 ± 16 62 ± 15 < 0.001
Number of significant 2.6 ± 0.6 2.6 ± 0.6 2.6 ± 0.6 0.441
stenosed coronary vessels
EuroScore 5.5 ± 3.6 5.1 ± 3.6 6.6 ± 3.5 < 0.001
CKD — chronic kidney disease; eGFR — estimated glomerular filtration rate; LDL — low-density lipoprotein; LVEDP — left ventricular end-diastolic pressure
Table 2. Independent variables that were related
to the gender difference.
Factors Odds ratio P
(95% CI)
Age (years) 0.96 (0.94-0.97) < 0.001
Smoking (%) 3.96 (2.53-6.19) < 0.001
Hypertension (%) 0.72 (0.54-0.95) 0.020
Diabetes mellitus (%) 0.67 (0.52-0.87) 0.003
Hyperuricemia  (%) 3.41 (1.95-5.96) < 0.001
Serum creatinine 1.10 (1.02-1.19) 0.013
[mg/dL]
Left ventricular 0.98 (0.97-0.99) < 0.001
ejection fraction (%)
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previous reports [6–8]. Our patients would not be
in a specific population. Based on the present data,
among patients with CABG, the difference in age
between males and females was only 4 years (the
average age in males and females was 66 ± 10 and
70 ± 8 years, respectively), while the age of onset
of CAD in females is almost 10 years younger than
that in males [3]. The criteria for patients to under-
go CABG according to Japanese guidelines were
a repeated coronary restenosis after PTCA in addi-
tion to three-vessel coronary artery disease and sig-
nificant coronary stenosis in the left main trunk [9].
CABG is generally considered the treatment of
choice for patients with severe stenotic lesions. Fe-
males with CAD are less likely than males to have
typical chest pain as a chief complaint. Herlitz et
al. [10] and Milner et al. [11] reported that, among
females, symptoms of myocardial infarction often
include back pain, abdominal pain and vomiting in
addition to, or instead of, chest pain. The diagnosis
of CAD in females is usually delayed compared to
that in males. Female patients may have been con-
sidered to be candidates for CABG because they
were in a more severe state. Thus, males may be
more likely to receive PTCA while females are se-
lected for CABG.
Although we did not analyze the influence of
menopause, the suppression of atherosclerosis by
estrogen reduces the incidence of CAD in younger
females. The risk of CAD in menopausal females
may be comparable to that in males. The ability of
estrogen to improve glucose and lipid metabolism
and its antihypertensive action [12], in addition to
its direct effects on the vessel wall [13] for prevent-
ing CAD, may be lost due to aging and menopause.
Thus, further studies are needed to confirm that
females who underwent CABG were older than
males because of menopause.
Table 3. Patient characteristics from G1 to G5 groups.
Group 1 Group 2 Group 3 Group 4 Group 5 Total P  for
trend
All patients
N 71 237 550 559 81 1498
Age (years) 44 ± 5 55 ± 3 65 ± 3 74 ± 3 82 ± 2 67 ± 9 < 0.001
Body mass index [kg/m2] 25 ± 4 24 ± 3 24 ± 3 23 ± 3 22 ± 3 24 ± 3 < 0.001
Male 94% 85% 79% 69% 57% 76% < 0.001
Smoking 39% 33% 23% 13% 7% 21% < 0.001
Hypertension 51% 65% 67% 71% 72% 67% 0.011
Diabetes mellitus 47% 53% 51% 46% 36% 48% 0.036
Hyperuricemia 17% 15% 11% 10% 7% 11% 0.064
Dyslipidemia 70% 67% 53% 55% 52% 57% 0.004
Male
N 67 202 433 385 46 1133
Age [years] 44 ± 5 55 ± 3 65 ± 3 74 ± 3 82 ± 2 66 ± 10 < 0.001
Body mass index [kg/m2] 25 ± 4 24 ± 3 24 ± 3 23 ± 3 23 ± 2 24 ± 3 < 0.001
Smoking 39% 35% 27% 18% 11% 25% < 0.001
Hypertension 51% 64% 66% 68% 63% 65% 0.091
Diabetes mellitus 43% 51% 49% 45% 35% 47% 0.229
Hyperuricemia 16% 17% 13% 12% 11% 14% 0.393
Dyslipidemia 70% 67% 52% 53% 48% 56% < 0.001
Female
N 4 35 117 174 35 365
Age [years] 44 ± 4 55 ± 3 65 ± 3 74 ± 3 83 ± 2 70 ± 8 < 0.001
Body mass index [kg/m2] 21 ± 4 24 ± 4 24 ± 4 23 ± 3 22 ± 3 23 ± 4 < 0.001
Smoking 50% 20% 6% 4% 3% 7% < 0.001
Hypertension 50% 66% 70% 75% 83% 73% 0.317
Diabetes mellitus 100% 66% 60% 48% 37% 53% 0.011
Hyperuricemia 25% 3% 4% 4% 3% 4% 0.317
Dyslipidemia 75% 66% 56% 59% 57% 59% 0.795
622
Cardiology Journal 2012, Vol. 19, No. 6
www.cardiologyjournal.org
Next, we address the effects of aging between
males and females for each coronary risk factor for
undergoing CABG. % smoking and % DL signifi-
cantly decreased and % HT increased with aging.
The incidence of smoking among Japanese peaks
in the 30 s among both males and females, and tends
to decline with aging. Smoking contributes to the
development of atherosclerosis and directly impairs
vascular endothelial cells. In addition, smoking in-
creases heart rate and blood pressure by stimulat-
ing sympathetic nerves [14], in addition to coagu-
lation factors and platelet function [15]. Epidemio-
logical studies have clearly shown that smoking sig-
nificantly increases the morbidity and mortality of
CAD [16]. Although older patients who underwent
CABG were expected to have higher rates of smok-
ing than younger patients, % smoking significantly
decreased with aging. The reason for this result is
unknown. Once patient has CAD, they may stop
smoking and then undergo CABG. It is important
to prevent smoking before it starts, especially in
adolescence. However, this registry did not analyze
Table 4. Physiological and biochemical parameters from G1 to G5 groups.
Group 1 Group 2 Group 3 Group 4 Group 5 Total P for
trend
All patients
N 71 237 550 559 81 1498
Serum creatinine [mg/dL] 1.8 ± 2.9 2.0 ± 3.1 1.4 ± 1.9 1.5 ± 1.9 1.2 ± 0.8 1.5 ± 2.1 0.003
CKD (stage) 2.3 ± 1.0 2.5 ± 1.1 2.6 ± 0.9 2.8 ± 0.8 2.8 ± 0.7 2.7 ± 0.9 < 0.001
eGFR [mL/min/1.73 mm2] 68 ± 26 62 ± 28 60 ± 23 52 ± 19 51 ± 19 57 ± 23 < 0.001
LDL-cholesterol [mg/dL] 113 ± 45 112 ± 37 116 ± 39 110 ± 39 111 ± 31 113 ± 39 0.092
LVEDP [mm Hg] 15 ± 7 15 ± 8 13 ± 7 14 ± 7 13 ± 7 14 ± 7 0.259
Left ventricular ejection 55 ± 17 57 ± 17 59 ± 15 60 ± 15 60 ± 17 59 ± 16 0.040
fraction (%)
Number of significant 2.5 ± 0.7 2.6 ± 0.6 2.6 ± 0.6 2.6 ± 0.6 2.6 ± 0.6 2.6 ± 0.6 0.052
stenosed coronary vessels
EuroScore 2.8 ± 2.9 3.0 ± 3.1 4.7 ± 3.1 7.1 ± 3.2 8.7 ± 3.5 5.5 ± 3.6 < 0.001
Male
N 67 202 433 385 46 1133
Serum creatinine [mg/dL] 1.8 ± 2.9 2.1 ± 3.2 1.4 ± 1.9 1.6 ± 2.0 1.3 ± 0.9 1.6 ± 2.3 0.005
CKD (stage) 2.4 ± 1.0 2.6 ± 1.1 2.6 ± 0.9 2.8 ± 0.8 2.8 ± 0.7 2.7 ± 0.9 < 0.001
eGFR [mL/min/1.73 mm2] 67 ± 26 60 ± 27 60 ± 22 52 ± 20 51 ± 18 57 ± 23 < 0.001
LDL-cholesterol [mg/dL] 115 ± 46 112 ± 37 117 ± 39 108 ± 37 108 ± 27 112 ± 38 0.017
LVEDP [mm Hg] 15 ± 7 15 ± 8 13 ± 7 14 ± 7 12 ± 6 14 ± 7 0.078
Left ventricular ejection 55 ± 17 55 ± 17 59 ± 15 59 ± 15 59 ± 15 58 ± 16 0.053
fraction (%)
Number of significant 2.5 ± 0.7 2.6 ± 0.7 2.6 ± 0.6 2.6 ± 0.6 2.7 ± 0.6 2.6 ± 0.6 0.183
stenosed coronary vessels
EuroScore 2.9 ± 3.0 3.0 ± 3.2 4.5 ± 3.1 6.8 ± 3.2 8.4 ± 3.7 5.1 ± 3.6 < 0.001
Female
N 4 35 117 174 35 365
Serum creatine [mg/dL] 0.7 ± 0.1 1.2 ± 2.0 1.4 ± 1.9 1.2 ± 1.6 1.0 ± 0.7 1.3 ± 1.7 0.808
CKD (stage) 1.8 ± 0.5 2.2 ± 1.0 2.5 ± 1.1 2.8 ± 0.8 2.8 ± 0.8 2.6 ± 1.0 0.006
eGFR [mL/min/1.73 mm2] 81 ± 20 71 ± 31 59 ± 26 51 ± 19 50 ± 20 56 ± 24 < 0.001
LDL-cholesterol [mg/dl] 82 ± 20 112 ± 35 115 ± 48 114 ± 40 116 ± 36 114 ± 42 0.633
LVEDP [mm Hg] 13 ± 6 12 ± 6 13 ± 7 14 ± 7 15 ± 7 13 ± 7 0.728
Left ventricular ejection 51 ± 13 67 ± 12 62 ± 14 62 ± 14 61 ± 19 62 ± 15 0.145
fraction (%)
Number of significant 2.3 ± 1.0 2.6 ± 0.6 2.6 ± 0.6 2.5 ± 0.7 2.6 ± 0.6 2.6 ± 0.6 0.561
stenosed coronary vessels
EuroScore 1.8 ± 0.5 3.1 ± 2.8 5.3 ± 2.8 7.7 ± 3.2 9.2 ± 3.2 6.6 ± 3.5 < 0.001
Abbreviations as in Table 1.
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the number of cigarettes smoked or the duration of
smoking.
% DL is high among males before age 50, and
becomes high in females after age 50 [17]. Howev-
er, in this registry, the rate was similar for both
males and females in each generation. Since % DL
in females in Group G1 + G2 (age < 60 years) was
relatively high, premenopausal females with DL
disproportionately underwent CABG. Premeno-
pausal females with lipid disorders are likely to re-
quire aggressive medical therapy. In the present
study, other lipid profiles, such as triglyceride, high-
-density lipoprotein cholesterol (HDL-C), non-
-HDL-C, and the ratio of LDL-C to HDL-C, were
not evaluated, and further studies are needed.
While DM is a risk factor for CAD, we could
not conclude that DM is a risk factor in gender or
age for CABG. Coronary stenotic lesions in patients
with DM generally show a small vessel diameter
and longer length, and the long-term prognosis of
percutaneous coronary intervention is worse than
that of CABG. The onset of DM at a younger age is
associated with severe CAD, and will require
CABG. Although there were no differences in
% DM with regard to gender or age, the risk for CAD
death in females with DM is 1.5 times higher than
that in males [18, 19].
The prevalence of HT is known to vary with
age in both males and females. In males, it increas-
es with age from the 30 s, peaks at around 70, and
remains constant thereafter. Meanwhile, the pre-
valence of HT in females increases rapidly after age
40, and the prevalence in females at age 70 is simi-
lar to that in males [20]. % HT in all patients in-
creased with aging in this study. This means that
HT may not be a particular risk factor for CABG.
However, eGFR was associated with HT, and the
values decreased with aging, which indicated that
older patients may require renal protection.
The EuroScore is useful for determining the risks
associated with CABG [21] and is routinely used in
clinical practice in Japan. Age (over 60 years plus
a score of 1 for every 5 years) and gender (female plus
a score of 1) are also included in the evaluation. In this
study, the EuroScore increased with aging in both
males and females, and the score in females was sig-
nificantly higher than that in males. Currently, the
Japan SCORE is being evaluated for the preoperative
assessment of risk for cardiac surgery using the Ja-
pan Cardiovascular Surgery Database.
Limitations of the study
This study has several limitations. First, this
is a single-center registry in patients who under-
went CABG. Second, CABG is performed far less
often in Japan than in Western countries, for se-
veral reasons: 1) Japanese hate surgery, 2) the dif-
ference in the number of physicians and surgeons,
and 3) the severity of atherosclerosis. We did not
take into account these factors in this registry.
Third, although the relation between aging and the
prevalence of hypertension seems to be more ob-
vious in females than in males, % HT in females
did not significantly increase with aging. In addition,
lower LDL-C levels were observed in female-G1.
These observations may be due to small sample size
of female-G1 and -G5. Forth, this registry is a ret-
rospective evaluation of the past 15 years, and the
therapeutic strategies used in recent patients may
be different from those in patients at the initial reg-
istration. Finally, we did not analyze the differenc-
es in patient characteristics between CAD patients
with and without CABG.
Conclusions
Decreases in % smoking and eGFR with aging
were common patient characteristics in both male and
female patients. Age, % smoking, % HT, % DM,
% HU, serum Cr and LVEF were related to the gender
identified independent variables. Therefore, before
CABG, high-risk patients with CAD who is going to
undergo CABG may need to be managed more strict-
ly considering to gender and age to avoid CABG.
Conflict of interest: none declared
References
1. Teramoto T, Sasaki J, Ueshima H et al. Risk factors of athero-
sclerotic diseases. Executive summary of Japan Atherosclerosis
Society (JAS) guideline for diagnosis and prevention of athero-
sclerosis cardiovascular diseases for Japanese. J Atheroscler
Thromb, 2007; 14: 267–277.
2. Yagi H, Komukai K, Hashimoto K et al. Difference in risk fac-
tors between acute coronary syndrome and stable angina pecto-
ris in the Japanese: smoking as a crucial risk factor of acute
coronary syndrome. J Cardiol, 2010; 55: 345–353.
3. Lawton JS. Sex and gender differences in coronary artery di-
sease. Semin Thorac Cardiovasc Surg, 2011; 23: 126–130.
4. Atkov OY, Gorokhova SG, Sboev AG et al. Coronary heart disease
diagnosis by artificial neural networks including genetic polymor-
phisms and clinical parameters. J Cardiol, 2012; 59: 190–194.
5. Nakamura M, Yamashita T, Yajima J et al.; Shinken Database
Study Group. Impact of early statin initiation on secondary pre-
vention in Japanese patients with coronary artery disease. J Car-
diol, 2011; 57: 172–180.
6. Kinoshita T, Asai T, Murakami Y, Suzuki T, Kambara A, Mat-
subayashi K. Preoperative renal dysfunction and mortality after
off-pump coronary artery bypass grafting in Japanese. Circ J,
2010; 74: 1866–1872.
624
Cardiology Journal 2012, Vol. 19, No. 6
www.cardiologyjournal.org
7. Orii K, Hioki M, Iedokoro Y, Shimizu K. Prognostic factors af-
fecting clinical outcomes after coronary artery bypass surgery:
Analysis of patients with chronic kidney disease after 5.9 years
of follow-up. J Nihon Med Sch, 2011; 78: 156–165.
8. Fukui T, Takanashi S. Gender differences in clinical and angio-
graphic outcomes after coronary artery bypass surgery. Circ J,
2010; 74: 2103–2108.
9. Kiyamura S. Guidelines for the clinical application of bypass
grafts and the surgical techniques. Circ J, 2006; 70 (suppl. VI):
1477–1553.
10. Herlitz J, Bång A, Karlson BW, Hartford M. Is there a gender
difference in aetiology of chest pain and symptoms associated
with acute myocardial infarction? Eur J Emerg Med, 1999; 6:
311–315.
11. Milner KA, Funk M, Richards S et al. Gender differences in
symptom presentation associated with coronary heart disease.
Am J Cardiol, 1999; 84: 396–339.
12. Lobo RA. Benefits and risks of estrogen replacement therapy.
Am J Obstet Gynecol, 1995; 173: 982–989.
13. Krasinski K, Spyridopoulos I, Asahara T, van der Zee R, Isner
JM, Losordo DW. Estradiol accelerates functional endothelial
recovery after arterial injury. Circulation, 1997; 95: 1768–1772.
14. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine
and epinephrine release and adrenergic mediation of smoking-
-associated hemodynamic and metabolic events. N Engl J Med,
1976; 295: 573–577.
15. Zidovetzki R, Chen P, Fisher M, Hofman FM, Faraci FM. Nico-
tine increases plasminogen activator inhibitor-1 production by
human brain endothelial cells via protein kinase cûassociated
pathway. Stroke, 1999; 30: 651–655.
16. Benowitz NL. Cigarette smoking and cardiovascular disease:
Pathophysiology and implications for treatment. Prog Cardio-
vasc Dis, 2003; 46: 91–111.
17. Thom T, Haase N, Rosamond W et al.; American Heart Associa-
tion Statistics Committee and Stroke Statistics Subcommittee.
Heart disease and stroke statistics — 2006 update: A report from
the American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Circulation, 2006; 113: e85–e151.
18. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on
coronary artery disease in women and men: a meta-analysis of
prospective studies. Diabetes Care, 2000; 23: 962–968.
19. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary
heart disease associated with diabetes in men and women: meta-
analysis of 37 prospective cohort studies. BMJ, 2006; 332: 73–78.
20. Staessen JA, Bieniaszewski L, O’Brien ET, Imai Y, Fagard R.
An epidemiological approach to ambulatory blood pressure moni-
toring: The Belgian Population Study. Blood Press Monit, 1996;
1: 13–26.
21. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S,
Salamon R, The EuroSCORE study Group. European system for
cardiac risk evaluation (EuroSCORE). Eur J Cardiothorac Surg,
1999; 16: 9–13.
